Jane A. Gross files SEC Form 4 disclosures for Aptevo Therapeutics Inc.. They have made 1 open-market trade across 1 company since 2025, most recently 2025-03-17.
CIK 0001684258
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $15K since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATYR | BUY | 2025-03-17 | 2025-03-17 | $4.00 | $15K | -21.4% | -27.2% | +32.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.